LEX Diagnostics Receives FDA 510(k) Clearance and CLIA Waiver for LEX VELO System
CAMBRIDGE, United Kingdom, Feb. 16, 2026 (GLOBE NEWSWIRE) — LEX Diagnostics, a leading innovator in molecular diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CLIA waived